Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany.

Translated title of the contribution: Healthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany.

B. Saller, A.F. Mattsson, P.H. Kann, H.P.F. Koppeschaar, J. Svensson, M. Pompen, M. Koltowska-Haggstrom

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionHealthcare utilization, quality of life and patient-reported outcomes during two years of GH replacement therapy in GH-deficient adults--comparison between Sweden, The Netherlands and Germany.
Original languageUndefined/Unknown
Pages (from-to)843-850
Number of pages8
JournalEuropean Journal of Endocrinology
Volume154
Issue number6
Publication statusPublished - 2006

Cite this